Compass Therapeutics Files 2024 10-K
Ticker: CMPX · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1738021
| Field | Detail |
|---|---|
| Company | Compass Therapeutics, Inc. (CMPX) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, biotech, financials
TL;DR
Compass Therapeutics filed its 2024 10-K, detailing its financial health and business operations for the year ending Dec 31, 2024.
AI Summary
Compass Therapeutics, Inc. filed its 2024 10-K on February 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, focused on biological products, is incorporated in Delaware and headquartered in Boston, MA. It was formerly known as Olivia Ventures, Inc. before a name change on April 19, 2018.
Why It Matters
This filing provides a comprehensive overview of Compass Therapeutics' financial performance and business operations for the fiscal year 2024, crucial for investors to assess the company's current standing and future prospects.
Risk Assessment
Risk Level: low — The provided text is a standard SEC filing header and does not contain specific financial or operational risks.
Key Players & Entities
- Compass Therapeutics, Inc. (company) — Filer
- Olivia Ventures, Inc. (company) — Former Company Name
- 02135 (dollar_amount) — ZIP Code
- 20250227 (date) — Filing Date
- 20241231 (date) — Fiscal Year End
FAQ
What is the primary business of Compass Therapeutics, Inc.?
Compass Therapeutics, Inc. is in the business of Biological Products (No Diagnostic Substances), as indicated by its Standard Industrial Classification code [2836].
When did Compass Therapeutics, Inc. change its name?
The company formerly known as Olivia Ventures, Inc. changed its name on April 19, 2018.
Where is Compass Therapeutics, Inc. located?
Compass Therapeutics, Inc. is located at 80 Guest Street, Boston, MA, with a ZIP code of 02135.
What is the SEC file number for Compass Therapeutics, Inc.'s 10-K filing?
The SEC file number for this filing is 001-39696.
What period does this 10-K filing cover?
This 10-K filing covers the fiscal year ending December 31, 2024.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding Compass Therapeutics, Inc. (CMPX).